Significant research has documented the impact of atopic dermatitis on mental health. Not only does stress trigger eczema ...

AD is a growing market with an impressive pipeline of new products from current and future players in the field.

The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...

A new study published in the Journal of European Academy of Dermatology and Venerology showed that compared to patients on ...

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in ...